Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study

European Journal of Cancer

Volumn 51, Issue 15, 2015, Pages 2191-2205

  Sant, Milena ^a   Chirlaque Lopez, Maria Dolores ^b,c   Agresti, Roberto ^a   Sánchez Pérez, Maria José ^c,d   Holleczek, Bernd ^e   Bielska Lasota, Magdalena ^f   Dimitrova, Nadya ^g   Innos, Kaire ^h   Katalinic, Alexander ⁱ   Langseth, Hilde ^j   Larrañaga, Nerea ^c,k   Rossi, Silvia ^l   Siesling, Sabine ^m,n   Minicozzi, Pamela ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Murcia Regional Health Authority   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^e SAARLAND CANCER REGISTRY   (Germany)

^f NATIONAL MEDICINES INSTITUTE   (Poland)

^g National Oncology Center Bulgaria   (Bulgaria)

^h NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

ⁱ UNIVERSITY OF LÜBECK   (Germany)

^j CANCER REGISTRY OF NORWAY   (Norway)

^k Public Mental Health Network of Gipuzkoa Osakidetza   (Spain)

^l ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^m The Netherlands Comprehensive Cancer Organisation   (Netherlands)

ⁿ UNIVERSITY OF TWENTE   (Netherlands)

more..

Author keywords

Breast cancer; Cervical cancer; Corpus uteri cancer; Europe; Ovarian cancer; Population based; Survival; Vaginal cancer; Vulval cancer

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BREAST CANCER; BULGARIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLLOID CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; CZECH REPUBLIC; EASTERN EUROPE; ENDOMETRIOID CARCINOMA; ESTONIA; ETHNIC DIFFERENCE; EUROPE; FEMALE; GENITAL TRACT CANCER; GERM CELL TUMOR; HUMAN; IRELAND; LATVIA; LITHUANIA; MAJOR CLINICAL STUDY; MIDDLE AGED; NORTHERN EUROPEAN; OVARY CANCER; OVERALL SURVIVAL; POLAND; PRIORITY JOURNAL; SARCOMA; SLOVAKIA; SLOVENIA; SOUTHERN EUROPE; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERUS CANCER; VAGINA CANCER; VULVA CANCER;

EID: 84942475466     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.07.022     Document Type: Article

References (56)

1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, H. Comber, and et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 Eur J Cancer 49 2013 1374 1403
2. M. Sant, C. Allemani, M. Santaquilani, A. Knijn, F. Marchesi, R. Capocaccia, and et al. Survival of cancer patients diagnosed in 1995-1999. Results and commentary Eur J Cancer 45 2009 931 991
3. E. Kampman, A. Vrieling, F.J. van Duijnhoven, and et al. Impact of diet, body mass index, and physical activity on cancer survival Curr Nutr Rep 1 2012 30 36
4. Collaborative Group on Hormonal Factors in Breast Cancer Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies Lancet Oncol 13 2012 1141 1151
5. E. Altobelli, and E. Lattanzi Breast cancer in European Union: an update of screening programmes as of March 2014 (Review) Int J Oncol 45 2014 1785 1792
6. Independent UK Panel on Breast Cancer Screening The benefits and harms of breast cancer screening: an independent review Lancet 380 2012 1778 1786
7. T. Bjørge, A. Engeland, S. Tretli, and et al. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women Int J Cancer 120 2006 378 383
8. R. Guido Secondary prevention of cervical cancer part 2: initial management of abnormal cervical cancer screening test Clin Obstet Gynecol 57 2014 292 301
9. Bruni L, Barrionuevo-Rosas L, Serrano B, Brotons M, Albero G, Cosano R, et al. Human papillomavirus and related diseases in World. Summary Report 2014-08-22. Available from http://www.hpvcentre.net/statistics/reports/XWX.pdf, accessed in March 2015.
10. M.L. Diaz Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine Int J Women's Health 1 2009 119 129
11. W. Oberaigner, P. Minicozzi, M. Bielska-Lasota, C. Allemani, R. De Angelis, L. Mangone, and et al. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade Acta Oncol 51 2012 441 453
12. C. Allemani, H.K. Weir, H. Carreira, R. Arewood, D. Spika, X.S. Wang, and et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet 385 2015 977 1010
13. A. Fritz, C. Percy, A. Jack, K. Shanmugaratnam, L. Sobin, D.M. Parkin, and et al. International classification of diseases for oncology 3rd ed. 2000 World Health Organization Geneva
14. S. Rossi, P. Baili, M. Caldora, E. Carrani, P. Minicozzi, D. Pierannunzio, and et al. The EUROCARE-5 study on cancer survival in Europe: database, quality checks and methods of statistical analysis Eur J Cancer 51 2015 2104 2119
15. F.A. Tavassoli, and P. Devilee World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs 2003 IARC Press Lyon
16. H. Brenner, and O. Gefeller Deriving more up-to-date estimates of long term patient survival J Clin Epidemiol 50 1997 211 216
17. H. Brenner, and T. Hakulinen Up-to-date long term survival curves of patients with cancer by period analysis J Clin Oncol 20 2002 826 832
18. D.M. Parkin, and T. Hakulinen Cancer registration: principles and methods. Analysis of survival IARC Sci Publ 1991 159 176
19. F. Ederer, and H. Heise Instructions to IBM 650 Programmers in processing survival computations. Methodological note No. 10. End Results Evaluation Section 1959 National Cancer Institute Bethesda, MD
20. H. Brenner, S. Francisci, R. De Angelis, R. Marcos-Gragera, A. Verdecchia, G. Gatta, and et al. Long term survival expectations of cancer patients in Europe in 2000-2002 Eur J Cancer 45 2009 1028 1041
21. I. Corazziari, M. Quinn, and R. Capocaccia Standard cancer patient population for age standardizing survival ratios Eur J Cancer 40 2004 4170 4176
22. R. De Angelis, M. Sant, M.P. Coleman, S. Francisci, P. Baili, D. Pierannunzio, and et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study Lancet Oncol 15 2014 23 34
23. M.L.G. Janssen-Heijnen, A. Gondos, F. Bray, T. Hakulinen, D.H. Brewster, H. Brenner, and et al. Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers J Clin Oncol 28 2010 2520 2528
24. M.P. Coleman, D. Forman, H. Bryant, J. Butler, B. Rachet, C. Maringe, and et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Lancet 377 2011 127 138
25. M. Pollán, R. Pastor-Barriuso, E. Ardanaz, M. Argüelles, C. Martos, J. Galcerán, and et al. Recent changes in breast cancer incidence in Spain, 1980-2004 J Natl Cancer Inst 101 2009 1584 1591
26. Steliarova-Foucher E, O'Callaghan M, Ferlay J, Masuyer E, Forman D, Comber H, et al. Cancer Incidence, Mortality, Prevalence and Survival in Europe. Version 1.0 (September 2012). European Network of Cancer Registries, International Agency for Research on Cancer. Available from http://eco.iarc.fr, accessed in March 2015.
27. J. Amaro, M. Severo, S. Vilela, S. Fonseca, F. Fontes, C. La Vecchia, and et al. Patterns of breast cancer mortality trends in Europe The Breast 22 2013 244 253
28. M. Arnold, H.E. Karim-Kos, J.W. Coebergh, G. Byrnes, A. Antilla, J. Ferlay, and et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory Eur J Cancer 51 2015 1164 1187
29. A. Goldhirsch, W.C. Wood, R.D. Gelber, A.S. Coates, B. Thurlimann, H.-J. Senn, and et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 2007 1133 1144
30. E. Senkus, S. Kyriakides, F. Penault-Llorca, P. Poortmans, A. Thompson, S. Zackrisson, and et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 24 2013 vi7 vi23
31. A. Thomas, R. Ohlinger, M. Hauschild, A. Mustea, J.U. Blohmer, and S. Kümmel Options and limits of surgery after pre-operative chemotherapy in breast cancer Anticancer Res 26 2006 1677 1682
32. E. Vilaprinyo, T. Puig, and M. Rue Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain PLoS One 7 2012 e30157
33. C. Bosetti, P. Bertuccio, M. Malvezzi, F. Levi, L. Chatenoud, E. Negri, and et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980 Ann Oncol 24 2013 2657 2671
34. M. Sant, C. Allemani, R. Capocaccia, T. Hakulinen, T. Aareleid, J.W. Coebergh, and et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe Int J Cancer 106 2003 416 422
35. N. Dimitrova, and I. Gavrilov Effect of adherence to breast cancer standards for treatment in Bulgaria D. Kalev, Management of breast cancer 2013 Art Treysar Varna
36. B. Holleczek, and H. Brenner Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland BMC Cancer 14 2014 757
37. O. Kjellgren Mass screening in Sweden for cancer of the uterine cervix: effect on incidence and mortality. An overview Gynecol Obstet Invest 22 1986 57-6
38. K.M. O'Brien, and L. Sharp Trends in incidence of, and mortality from, cervical lesions in Ireland: baseline data for future evaluation of the national cervical screening programme Cancer Epidemiol 37 2013 830 835
39. Scottish Cervical Screening Programme. http://www.isdscotland.org/Health-Topics/Cancer/Cervical-Screening/.
40. J.A. Rauh-Hain, R.J. Vargas, J. Clemmer, R.M. Clark, L.S. Bradford, W.B. Growdon, and et al. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: a SEER analysis Am J Clin Oncol 2014 [Epub ahead of print]
41. T. Bjørge, T. Stocks, A. Lukanova, S. Tretli, R. Selmer, J. Manjer, and et al. Metabolic syndrome and endometrial carcinoma Am J Epidemiol 8 2010 892 902
42. R.J. Kurman, and IeM. Shih Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications Int J Gynecol Pathol 27 2008 151 160
43. G.D. Aletti, S.C. Dowdy, K.C. Podratz, and W.A. Cliby Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer Gynecol Oncol 100 2006 283 287
44. J.K. Chan, R. Urban, M.K. Cheung, K. Osann, J.Y. Shin, A. Husain, and et al. Ovarian cancer in younger vs older women: a population-based analysis Br J Cancer 95 2006 1314 1320
45. M. Akeson, B.M. Zetterqvist, E. Holmberg, and G. Horvath Improved survival with clinical guidelines? Evaluation of a quality register linked to clinical guidelines for ovarian cancer in the western health care region in Sweden between 1 September 1993 and 1 June 1998 Acta Obstet Gynecol Scand 84 2005 1113 1118
46. S. Kumpulainen, S. Grénman, P. Kyyrönen, E. Pukkala, and R. Sankila Evidence of benefit from centralised treatment of ovarian cancer: a nationwide population-based survival analysis in Finland Int J Cancer 102 2002 541 544
47. W. Oberaigner, and W. Stuhlinger Influence of department volume on cancer survival for gynaecological cancers-a population-based study in Tyrol, Austria Gynecol Oncol 103 2006 527 534
48. G. Deppe, I. Mert, and I.S. Winer Management of squamous cell vulvar cancer: a review J Obstet Gynaecol Res 40 2014 1217 1225
49. I. Alonso, A. Felix, A. Torné, V. Fusté, M. del Pino, P. Castillo, and et al. Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina Gynecol Oncol 125 2012 194 199
50. F. Berrino The EUROCARE study: strengths, limitations and perspectives of population-based, comparative survival studies Ann Oncol 14 2003 v9 v13
51. R. Zanetti, I. Schmidtmann, L. Sacchetto, F. Binder-Foucard, A. Bordoni, D. Coza, and et al. Completeness and timeliness: cancer registries could/should improve their performance Eur J Cancer 51 2015 1091 1098
52. G. Lyratzopoulos, R.D. Neal, J.M. Barbiere, G.P. Rubin, and G.A. Abel Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 national cancer patient experience survey in England Lancet Oncol 13 2012 353 365
53. P. Baili, F. Di Salvo, R. Marcos-Gragera, S. Siesling, S. Mallone, M. Santaquilani, and et al. Survival for all cancer patients diagnosed between 1999 and 2007 in Europe: results of EUROCARE-5, a population-based study Eur J Cancer 51 2015 2120 2129
54. A. Sagan, D. Panteli, W. Borkowski, M. Dmowski, F. Domanski, M. Czyzewski, and et al. Poland health system review Health Syst Transit 13 2011 1 193
55. S. Siesling, W.J. Louwman, A. Kwast, C. van den Hurk, M. O'Callaghan, S. Rosso, and et al. Uses of cancer registries for public health and clinical research in Europe: results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010-2012 Eur J Cancer 51 2015 1039 1049
56. M.S. Thong, F. Mols, K.D. Stein, T. Smith, J.W. Coebergh, and L.V. van de Poll-Franse Population-based cancer registries for quality-of-life research: a work-in-progress resource for survivorship studies? Cancer 119 2013 2109 2123